Avalo Therapeutics (AVTX) vs Olema Pharmaceuticals (OLMA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Avalo Therapeutics (AVTX) has outperformed Olema Pharmaceuticals (OLMA) over the past year, gaining 0.7% versus a loss of 23.9%. Over five years, OLMA leads with a -74.1% price change compared with -99.8% for AVTX. Avalo Therapeutics is the larger company by market cap ($728.3 million vs $694.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVTX | OLMA |
|---|---|---|
| Share price | $13.58 | $7.94 |
| Market cap | $728.30M | $694.73M |
| 1-day change | -0.07% | +0.25% |
| YTD return | -25.22% | -68.24% |
| 1-year return | +0.74% | -23.95% |
| 5-year return | -99.79% | -74.15% |
| EPS (TTM) | $-4.31 | $-2.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.27 | $36.26 |
| 52-week low | $12.51 | $6.65 |
| Distance from 52-week high | -44.05% | -78.10% |
| Average volume | 929.44K | 1.07M |
| Shares outstanding | 53.63M | 87.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AVTX has outperformed OLMA by 24.7 percentage points over the past year.
AVTX vs OLMA FAQ
Which is bigger, Avalo Therapeutics or Olema Pharmaceuticals?
Avalo Therapeutics (AVTX) is larger, with a market capitalization of $728.30M compared with $694.73M for Olema Pharmaceuticals (OLMA).
Which stock has performed better over the past year, AVTX or OLMA?
AVTX returned +0.74% over the past 12 months, compared with -23.95% for OLMA (price return, excluding dividends). Past performance does not predict future results.
Are Avalo Therapeutics and Olema Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.